Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-18

FDA Approved: PIRFENIDONE — Original Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a generic version of pirfenidone from Micro Labs Limited through an Original Application (ANDA) for idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)